Using the 90th percentiles of the CV values as a limit for clinical change means that the concentration of NGAL has to change by 83.3%, KIM1 by 45.5% and Cystatin C by 46.3% before the change can be considered clinically significant in patients with chronic kidney disease. This evidence concerns the gene CST3 and chronic kidney disease.